PHARMACEUTICAL QUALITY CONTROL TESTING – Qatar MoPH & GCC Compliant Laboratory

Pharmaceutical Quality Control Testing is the scientific verification process that ensures every raw material, intermediate, and finished pharmaceutical product meets approved specifications before reaching patients.

In Qatar’s highly regulated healthcare environment, quality control testing is not only a GMP requirement — it is the analytical backbone that protects patient safety, supports regulatory compliance, and sustains pharmaceutical market authorization.

Mets Lab Qatar provides comprehensive PHARMACEUTICAL QUALITY CONTROL TESTING in Qatar, aligned with Ministry of Public Health (MoPH) regulations, GCC harmonized standards, and international pharmacopeial requirements.

Why PHARMACEUTICAL QUALITY CONTROL TESTING is Critical in Qatar

• Patient Safety & Therapeutic Reliability:

  QC testing confirms that medications distributed across Qatar:
  • Contain the correct active ingredient
  • Meet approved potency levels
  • Are free from harmful impurities
  • Maintain microbiological safety
  • Perform consistently batch after batch
  In advanced healthcare institutions across Qatar, analytical reliability directly impacts treatment outcomes



• Mandatory Regulatory Compliance:

  All pharmaceutical products registered with Qatar MoPH must undergo validated QC testing prior to:
  • Product registration approval
  • Batch release authorization
  • Import clearance
  • Post-approval change submission
  Testing must align with Good Manufacturing Practice (GMP) requirements under Qatar pharmaceutical law.



• Market Protection & Risk Prevention:

  Comprehensive quality control programs prevent:
  • Product recalls
  • Regulatory enforcement actions
  • Import rejections
  • Manufacturing license suspension
  • Brand damage in GCC markets
  Robust QC testing strengthens both compliance and commercial credibility.

Standards & Regulatory Framework We Follow

• Qatar General Organization for Standards and Metrology:

  Laboratory competence aligned with national quality infrastructure and ISO/IEC 17025 accreditation principles.



• Gulf Cooperation Council (GCC):

  Testing programs structured to support centralized GCC pharmaceutical registration pathways.



• United States Pharmacopeia (USP):




• European Pharmacopoeia (EP):




• World Health Organization (WHO):

Analytical methodologies conform to internationally recognized pharmacopeial monographs accepted by Qatar MoPH for products manufactured under FDA, EMA, or WHO-certified GMP facilities.

Industries We Serve in Qatar

Our Distinctive Strengths

Advanced Analytical Infrastructure

State-of-the-art instrumentation portfolio including:

• UPLC-MS systems
• Gas Chromatography (GC)
• ICP-MS for elemental impurities
• Atomic spectroscopy
• High-resolution chromatographic systems

Qatar Regulatory Expertise

Deep understanding of documentation formats, testing frequencies, and regulatory submission expectations required by the Pharmacy & Drug Control Department.

Method Development & Validation

Analytical method validation aligned with ICH Q2 principles, ensuring suitability for regulatory submissions and lifecycle quality monitoring.

Climate-Specific Testing Insight

Specialized protocols evaluating pharmaceutical stability and performance under Qatar’s extreme environmental conditions.

Rapid Turnaround & High-Volume Capacity

Efficient workflow systems supporting:

• Commercial batch release
• Import verification
• Manufacturing scale-up
• Technology transfer validation

ISO/IEC 17025 Aligned Quality Systems

Comprehensive documentation, equipment qualification, personnel competency, and data integrity controls ensuring inspection readiness